Scientific Analysis: No AIDS-Polio Vaccine Link

At a Sept. 11 meeting of the Royal Society of London, convened to discuss the origin of HIV/AIDS, researchers aired scientific data showing that the hypothesis that HIV/AIDS originated from an experimental oral polio vaccine had no scientific merit. The hypothesis was popularized by journalist Edward Hooper in his 1999 book, The River,1 and supported by the late evolutionary biologist William Hamilton. It states that a type of oral poliovirus vaccine (OPV) called CHAT, produced by Hilary Koprows

Written byMyrna Watanabe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At a Sept. 11 meeting of the Royal Society of London, convened to discuss the origin of HIV/AIDS, researchers aired scientific data showing that the hypothesis that HIV/AIDS originated from an experimental oral polio vaccine had no scientific merit. The hypothesis was popularized by journalist Edward Hooper in his 1999 book, The River,1 and supported by the late evolutionary biologist William Hamilton. It states that a type of oral poliovirus vaccine (OPV) called CHAT, produced by Hilary Koprowski and colleagues from the Wistar Institute, Philadelphia, and other polio vaccine researchers in Africa, was derived from culture of the virus in chimpanzee kidneys that were contaminated with SIV (simian immunodeficiency virus). Koprowski is now professor of microbiology and immunology at Jefferson Medical College, Philadelphia.

The Royal Society meeting, organized by Hamilton and originally scheduled to occur last May (which turned out to be several weeks after Hamilton's untimely death from complications ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies